CH610329A5 - Process for the preparation of stable crystalline salts of cephalosporins - Google Patents
Process for the preparation of stable crystalline salts of cephalosporinsInfo
- Publication number
- CH610329A5 CH610329A5 CH406076A CH406076A CH610329A5 CH 610329 A5 CH610329 A5 CH 610329A5 CH 406076 A CH406076 A CH 406076A CH 406076 A CH406076 A CH 406076A CH 610329 A5 CH610329 A5 CH 610329A5
- Authority
- CH
- Switzerland
- Prior art keywords
- stable crystalline
- cephalosporins
- crystalline salts
- preparation
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
In order to obtain stable crystalline salts of formula <IMAGE> a solution of cephalosporanic acid (formula I, X = H) is reacted with a solution of a compound XQ (X = Li or an ammonium residue and Q = anion of an acid HQ of pKa of 4 or more) and the salt obtained is crystallised. The compounds exhibit antibacterial properties.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1467475A GB1546757A (en) | 1975-04-10 | 1975-04-10 | Crystalline cephalosporin salts |
Publications (1)
Publication Number | Publication Date |
---|---|
CH610329A5 true CH610329A5 (en) | 1979-04-12 |
Family
ID=10045536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH406076A CH610329A5 (en) | 1975-04-10 | 1976-04-01 | Process for the preparation of stable crystalline salts of cephalosporins |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS51148010A (en) |
CA (1) | CA1079719A (en) |
CH (1) | CH610329A5 (en) |
ES (1) | ES446743A1 (en) |
GB (1) | GB1546757A (en) |
NL (1) | NL188351C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0485103A2 (en) * | 1990-11-05 | 1992-05-13 | Eli Lilly And Company | Process for cleavage of esters during the production of cephalosporins |
EP0557035A2 (en) * | 1992-02-18 | 1993-08-25 | Eli Lilly And Company | An ester cleavage process for use with beta-lactams |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4448958A (en) * | 1982-10-20 | 1984-05-15 | Bristol-Myers Company | Purification of ceforanide |
-
1975
- 1975-04-10 GB GB1467475A patent/GB1546757A/en not_active Expired
-
1976
- 1976-03-23 CA CA248,597A patent/CA1079719A/en not_active Expired
- 1976-04-01 CH CH406076A patent/CH610329A5/en not_active IP Right Cessation
- 1976-04-06 ES ES76446743A patent/ES446743A1/en not_active Expired
- 1976-04-07 NL NL7603617A patent/NL188351C/en not_active IP Right Cessation
- 1976-04-08 JP JP4016076A patent/JPS51148010A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0485103A2 (en) * | 1990-11-05 | 1992-05-13 | Eli Lilly And Company | Process for cleavage of esters during the production of cephalosporins |
EP0485103A3 (en) * | 1990-11-05 | 1992-09-16 | Eli Lilly And Company | Process for cleavage of esters during the production of cephalosporins |
EP0557035A2 (en) * | 1992-02-18 | 1993-08-25 | Eli Lilly And Company | An ester cleavage process for use with beta-lactams |
EP0557035A3 (en) * | 1992-02-18 | 1993-12-01 | Lilly Co Eli | An ester cleavage process for use with beta-lactams |
Also Published As
Publication number | Publication date |
---|---|
NL188351C (en) | 1992-06-01 |
ES446743A1 (en) | 1977-06-01 |
GB1546757A (en) | 1979-05-31 |
NL7603617A (en) | 1976-10-12 |
CA1079719A (en) | 1980-06-17 |
NL188351B (en) | 1992-01-02 |
JPS51148010A (en) | 1976-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8304045D0 (en) | DERIVATIVES OF MORPHOLINYL-DAUNORUBICIN AND MORPHOLINYL-DOXORUBICIN AND ANALOGS THEREOF, AND PROCEDURE FOR PREPARING THEREOF | |
SE7601930L (en) | WAY TO PREPARE HOGRENA, SEVERAL CYANIC ACID ESTERS | |
ES412859A1 (en) | Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof | |
CH610329A5 (en) | Process for the preparation of stable crystalline salts of cephalosporins | |
ES8105692A1 (en) | Process for preparing 2-nitro-5-(substituted-phenoxy) benzoic acids and salts thereof. | |
GB1285610A (en) | Quinacridone pigments | |
EP0134179A3 (en) | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them | |
DE3568580D1 (en) | Process for preparing alkanephosphonous acids | |
HUT41015A (en) | Process for preparing amino-thiazole-acetic acid derivatives | |
ES500980A0 (en) | PROCEDURE FOR PREPARING ALCOXI PROPANOLAMINES | |
ES447615A1 (en) | Derivatives of 7-aminocephalosporanic acid | |
KR880003959A (en) | Crystalline Cefem Carboxylic Acid Addition Salt | |
GB1027030A (en) | New anthranilic acid compounds | |
GB1079726A (en) | Method of producing a new salicylic acid ester | |
GB2001643A (en) | Preparing aqueous solutions of alkali metal salts of Armstrong acid | |
ES445336A1 (en) | Oxoindanylpropionic acids and process for the preparation thereof | |
GB1032641A (en) | Cephalosporins | |
GB2012270A (en) | Crystallisation process for sodium cefuroxime | |
GB1085083A (en) | Improvements in or relating to benzimidazoles and the manufacture thereof | |
EP0111569A4 (en) | Hydroxyalkanesulfonic acids and their derivatives, and process for their preparation. | |
ES457558A1 (en) | Process for the preparation of aminonitrophenols | |
GB1082184A (en) | Thiamine derivatives | |
JPS5728070A (en) | Monosodium salt dihydrate of 1,2,3-triazole-5-thiol and its preparation | |
GB1332090A (en) | Optical resolution of salts of dl-2-pyrolidone-5-carboxylic acid | |
GB1537903A (en) | 7-(alpha-(2-oxo-imidazolidin-1-yl-carbonylamino)-phenylacetamido)-cephalosporins processes for their preparation and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |